After decades of struggle, we’re finally seeing real-world, life-changing applications right here in Philadelphia. Has medicine finally got gene therapy right?
NextHealth PHL covers the healthcare industry in Philadelphia and the work of scientists, doctors, and healthcare companies in Cellicon Valley. NextHealth PHL puts a special emphasis on healthcare news in the vibrant cell and gene therapies sector.
The Cancer Epigenetics Institute aims to increase therapy options for cancer patients and to promote educational opportunities for students and faculty.
The grant will allow for a more than 40,000-square-foot addition to their biopharmaceutical and biologics education and training center.
BioLattice is currently working on a prototype made from biologics and synthetic polymers.
The test is designed to work with existing RT-PCR instruments, meaning folks can now be screened for novel variants in addition to the original coronavirus.
Their findings reveal that Black, Latinx, and lower-income patients receive less early intervention for atrial fibrillation.
SOLUtion Medical’s TwistJect device allows people living with adrenal insufficiency to quickly and safely inject rescue medication in one step.
The Philly-based biotech company will begin human testing of EBT-101, a CRISPR-based gene editing construct developed at Temple’s Lewis Katz School of Medicine.
Here’s how Neuma works to ensure pharmaceutical and medtech companies are set up for success as they bring their products to market.
The program is working to improve the health and well-being of Montgomery County-based Black pregnant women, infants, and their families.
Project Onramp is seeking to bridge the opportunity gap for low-income and first-generation college students.
Researchers at Jefferson Are Working to Improve Stroke Patients’ Long-Term Mobility With Brain Implants
Their recent clinical trial, which used implanted brain electrodes and a motorized brace to restore movement in a paralyzed arm, aims to pave the way for a fully implantable, wireless medical device.
Penn Medicine’s Interventional Support Center will clean and re-package surgical supplies for their hospitals and outpatient centers.
TELA Bio is striving to reduce the adverse effects of hernia repair with OviTex, their biological material-based surgical mesh product.
Newborn Babies Can Receive COVID-19 Antibodies From Mothers While in Utero, According to New Penn Study
The study conducted at Pennsylvania Hospital from April to August last year suggests that mothers who have had COVID-19 can provide some protection against the virus to their infants.
With an established, yet continually growing market, Philadelphia is ranked among Boston, San Francisco and others on Newmark’s 2020 year-end report.